Medicines360 Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Medicines360's estimated annual revenue is currently $11.9M per year.(i)
  • Medicines360's estimated revenue per employee is $296,475

Employee Data

  • Medicines360 has 40 Employees.(i)
  • Medicines360 grew their employee count by -18% last year.

Medicines360's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
EVP, Policy and Strategic Market AccessReveal Email/Phone
3
VP, Strategic DevelopmentReveal Email/Phone
4
VP Product DevelopmentReveal Email/Phone
5
VP, Finance & AccountingReveal Email/Phone
6
SVP, Quality and Product SafetyReveal Email/Phone
7
VP Commercial and Business DevelopmentReveal Email/Phone
8
Director Corporate AffairsReveal Email/Phone
9
Director Regulatory AffairsReveal Email/Phone
10
Senior Director, Clinical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M542-3%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M1634-2%N/AN/A
#10
$10.5M4812%N/AN/A
Add Company

What Is Medicines360?

Medicines360 is a non-profit pharmaceutical company and social enterprise working toward self-sustainability through commercial sales revenue that develops innovative, affordable, and sustainable medical solutions for women. Profit is a means of achieving our mission, not our motive; we exist to meet the medical needs of all women.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$11.9M

Revenue (est)

-18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medicines360 News

2022-04-17 - Global Intrauterine Contraceptive Devices (IUCD) Market ...

... (IUCD) Market 2022 Growth Statistics by Key Vendors – Bayer Healthcare AG, Teva Pharmaceutical Industries Ltd, Actavis PLC, Medicines360.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.2M4090%$14.5M
#2
$4.4M40-5%$60M
#3
$12M40-51%$39M
#4
$8.1M40N/AN/A
#5
$10.4M40N/AN/A